CVS Health (CVS) will report third-quarter earnings before the market opens Wednesday after the pharmacy and health-care provider had a rocky October that included a CEO change and layoffs, among other cost-cutting moves.
Besides Wall Street's top -and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) closed at $56.25 in the latest trading session, marking a -1.94% move from the prior day.
CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.
CVS Health dropped ~10% following Q3 earnings, impacted by a $1.1B Medicare charge and a $1.2B restructuring charge. CVS's FY2024 EPS forecast is $6.47, down 26.01% YoY, reflecting financial challenges, but FY2025 recovery is projected at $7.30, up 13%. The company's revenue is estimated at $369.25 billion in 2024, with upward revisions suggesting optimism, projected to reach $386.28 billion by 2025.
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
At the present rate, it will take 81 years to achieve gender parity among the CEO class
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
The new chief executive officer of CVS Health is schooled in many of the traditions that built the company into a major player in both health insurance and healthcare delivery. So don't look for David Joyner to move away from vertical integration as both a provider and a health insurance company.
Workers at seven CVS pharmacies in California are now on strike, seeking better pay and health care, as the stores remain open and staffed by managers and nonunion employees.
If you buy these stocks, you might be in for serious disappointment when they underperform.